Amneal Pharmaceuticals (AMRX) SEC Filings & 10K Form

$6.71
+0.05 (+0.75%)
(As of 05/13/2024 ET)

Recent Amneal Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/08/2024
3:46 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:18 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
4:19 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:23 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:28 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:31 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:34 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:35 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:38 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
5:03 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
03/22/2024
7:01 AM
Amneal Pharmaceuticals (Filer)
Form DEF 14A
03/22/2024
7:01 AM
Amneal Pharmaceuticals (Filer)
Form DEFA14A
03/14/2024
4:04 PM
Amneal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
4:39 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:40 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:54 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:40 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:13 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
6:03 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:09 PM
Amneal Pharmaceuticals (Subject)
Mahesh Akram (Filed by)
Form SC 13G
01/03/2024
3:30 PM
Amneal Pharmaceuticals (Subject)
Patel Gautam (Filed by)
Form SC 13D/A
12/26/2023
6:06 PM
Amneal Pharmaceuticals (Filer)
Form CERT
12/26/2023
3:10 PM
Amneal Pharmaceuticals (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
12/12/2023
5:04 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
11/20/2023
5:07 AM
Amneal Pharmaceuticals (Filer)
Form 15-12G
11/14/2023
11:15 PM
Amneal Pharmaceuticals (Filer)
Form EFFECT
11/14/2023
11:15 PM
Amneal Pharmaceuticals (Filer)
Form EFFECT
11/08/2023
5:20 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
5:21 PM
Amneal Pharmaceuticals (Issuer)
Patel Dipan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
5:21 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
5:22 PM
Amneal Pharmaceuticals (Issuer)
Patel Tushar Bhikhubhai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
5:20 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
4:03 PM
Amneal Pharmaceuticals (Subject)
Patel Gautam (Filed by)
Form SC 13D/A
11/08/2023
4:05 PM
Amneal Pharmaceuticals (Subject)
Patel Dipan (Filed by)
Form SC 13D/A
11/08/2023
4:07 PM
Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
Form SC 13D/A
11/08/2023
4:12 PM
Amneal Pharmaceuticals (Filer)
Form POS AM
11/08/2023
4:13 PM
Amneal Pharmaceuticals (Filer)
Form POS AM
11/08/2023
4:13 PM
Amneal Pharmaceuticals (Filer)
Form S-8 POS
11/08/2023
4:14 PM
Amneal Pharmaceuticals (Filer)
Form S-8 POS
11/08/2023
4:15 PM
Amneal Pharmaceuticals (Filer)
Form S-8 POS
America’s worst nightmare? (Ad)

What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.

Click here to watch this bombshell exposé now.
11/08/2023
8:36 AM
Amneal Pharmaceuticals (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
11/08/2023
6:40 AM
Amneal Pharmaceuticals (Filer)
Form 8-K12B
11/07/2023
5:21 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
3:16 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
5:51 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2023
3:30 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
2:30 PM
Amneal Pharmaceuticals (Subject)
BOYER ANDREW S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2023
11:24 AM
Amneal Pharmaceuticals (Subject)
BOYER ANDREW S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
7:32 AM
Amneal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/04/2023
5:22 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
3:30 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:30 PM
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:30 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AMRX) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners